Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline--an open clinical trial.
Open Access
- 1 May 2000
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Sleep
- Vol. 23 (3) , 1-6
- https://doi.org/10.1093/sleep/23.3.1b
Abstract
To define the effective dose of cabergoline and to evaluate the tolerability and efficacy of cabergoline in patients with restless legs syndrome (RLS).Keywords
This publication has 0 references indexed in Scilit: